Nimisha Kumar, MD
she/her/hers
Clinical FellowAbout
Research
Publications
2025
Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss
Cheng T, Kumar N, Laursen L, Achilles S, Reeves M, Atrio S. Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss. Contraception 2025, 148: 110895. PMID: 40154660, DOI: 10.1016/j.contraception.2025.110895.Peer-Reviewed Original ResearchConceptsManagement of pregnancy lossCenters for Disease Control and Prevention guidelinesUniversal antibiotic prophylaxisPrevention of infectionAntibiotic prophylaxisProcedural abortionPregnancy lossGrade 1CGrade 1bMedical managementGrade 1ASingle doseManagement of early pregnancy lossMedical management of early pregnancy lossSingle dose of doxycyclineRoutine antibiotic prophylaxisProcedural managementSecond-line optionUS Preventive Services Task Force recommendationsRisk of side effectsDose of doxycyclineEarly pregnancy lossClinical care of patientsDiagnosis of gonorrheaInsufficient evidence
2024
The Association between Sleep and Depression during Late Pregnancy and the Early Postpartum Period
Jones A, Hadaie B, Bennett R, Kumar N, Saha C, Haas D. The Association between Sleep and Depression during Late Pregnancy and the Early Postpartum Period. American Journal Of Perinatology Reports 2024, 14: e11-e15. PMID: 38269127, PMCID: PMC10805570, DOI: 10.1055/s-0043-1778003.Peer-Reviewed Original ResearchEdinburgh Postnatal Depression ScaleElevated EPDS scoresPittsburgh Sleep Quality IndexEPDS scoresEarly postpartum periodSleep qualityAssociated with higher EPDS scoresMonths postpartumPostpartum periodHigher EPDS scoresPoor sleepPostnatal Depression ScalePoor sleep scoreSleep Quality IndexHigher PSQI scoresLate pregnancyDepression ScaleDepressive mood symptomsPearson correlation coefficientDepressive symptomsPSQI scoreGestational ageMood symptomsIndividual time pointsSleep scores
2023
Turning Rage Into Action: Abortion Care and Residency Training in the United States.
Bauer C, Jackson A, Kumar N, Bauer K, Zite N. Turning Rage Into Action: Abortion Care and Residency Training in the United States. Journal Of Graduate Medical Education 2023, 15: 291-295. PMID: 37363662, PMCID: PMC10286934, DOI: 10.4300/jgme-d-23-00319.1.Peer-Reviewed Original Research
2022
Medical Student Perspectives on the Ethics of Pelvic Exams Under Anesthesia: A Multi-Institutional Study✰
Kaur K, Salwi S, McNew K, Kumar N, Millimet H, Ravichandran N, Tytus K, Zhang A, Garrett Wood A, Grimm B, Fairbrother E. Medical Student Perspectives on the Ethics of Pelvic Exams Under Anesthesia: A Multi-Institutional Study✰. Journal Of Surgical Education 2022, 79: 1413-1421. PMID: 35672245, DOI: 10.1016/j.jsurg.2022.05.015.Peer-Reviewed Original ResearchConceptsUniversity School of MedicineSchool of MedicineFemale pelvic anatomyMulti-institutional studyEmory University School of MedicineMedical studentsPelvic examinationGynecologic surgeryPelvic anatomyPelvic examPatient autonomyObservation patientsPatientsProfessional ethical normsPatient consent processMedical CollegeIndiana University School of MedicineVanderbilt University School of MedicineRoutine componentWarren Alpert Medical School of Brown UniversityAlpert Medical School of Brown UniversityConsent processEthical normsMeharry Medical CollegeEUA
2021
Misoprostol for labour induction
Kumar N, Haas D, Weeks A. Misoprostol for labour induction. Best Practice & Research Clinical Obstetrics & Gynaecology 2021, 77: 53-63. PMID: 34607746, DOI: 10.1016/j.bpobgyn.2021.09.003.Peer-Reviewed Original ResearchConceptsVaginal birthVaginal misoprostolOral misoprostolCaesarean sectionRate of caesarean sectionCaesarean section rateFoetal heart rate changesPerinatal adverse eventsUterine hyperstimulationBalloon catheterLabor inductionSection rateEffective induction methodMisoprostolNeonatal complicationsHeart rate changesNo significant differenceRandomised comparisonAdverse eventsSide effectsBirthSignificant differenceHyperstimulationCatheterDinoprostoneMedical cannabis or cannabinoids for chronic pain: a clinical practice guideline
Busse J, Vankrunkelsven P, Zeng L, Heen A, Merglen A, Campbell F, Granan L, Aertgeerts B, Buchbinder R, Coen M, Juurlink D, Samer C, Siemieniuk R, Kumar N, Cooper L, Brown J, Lytvyn L, Zeraatkar D, Wang L, Guyatt G, Vandvik P, Agoritsas T. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. The BMJ 2021, 374: n2040. PMID: 34497062, DOI: 10.1136/bmj.n2040.Peer-Reviewed Original ResearchConceptsChronic painMedical cannabisShared decision makingNon-cancer causesIndividual patient perspectiveHarms of medical cannabisClinical practice guidelinesNon-cancer painGuideline development panelTransient harmsPhysical functionPatient perspectiveTrustworthy guidelinesPatient valuesPain intensityStandard careGuideline recommendationsPractice guidelinesGRADE approachExpert panelSystematic reviewSleep qualityDevelopment panelChronic cancerSocioeconomic burdenLow‐dose oral misoprostol for induction of labour
Kerr R, Kumar N, Williams M, Cuthbert A, Aflaifel N, Haas D, Weeks A. Low‐dose oral misoprostol for induction of labour. Cochrane Database Of Systematic Reviews 2021, 2021: cd014484. PMID: 34155622, PMCID: PMC8218159, DOI: 10.1002/14651858.cd014484.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntravaginalAdministration, OralApgar ScoreCesarean SectionDinoprostoneDrug Administration ScheduleFemaleHeart Rate, FetalHumansIntensive Care, NeonatalLabor, InducedMisoprostolOxytocicsOxytocinParturitionPlacebosPregnancyRandomized Controlled Trials as TopicTime FactorsUterusConceptsLow-dose oral misoprostolFoetal heart rate changesTranscervical Foley catheterVaginal birthRates of hyperstimulationOral misoprostolLow-dose misoprostolVaginal dinoprostoneCaesarean sectionHeart rate changesUterine hyperstimulationLabor inductionVaginal misoprostolRate of vaginal birthFoetal distressRisk of uterine hyperstimulationRate of caesarean sectionRisk of caesarean sectionThird trimesterLabour induction methodsFoley catheterChildbirth's Trials RegisterSubgroup analysisWHO International Clinical Trials Registry PlatformAssociated with similar ratesUmbilical vein injection for management of retained placenta
Kumar N, Jahanfar S, Haas D, Weeks A. Umbilical vein injection for management of retained placenta. Cochrane Database Of Systematic Reviews 2021, 2021: cd001337. PMID: 33705565, PMCID: PMC8094279, DOI: 10.1002/14651858.cd001337.pub3.Peer-Reviewed Original ResearchConceptsUmbilical vein injectionSevere postpartum haemorrhageVery-low certaintyRisk of biasExpectant managementBlood transfusionPostpartum anemiaPostpartum haemorrhageRandomised controlled trialsOxytocin solutionTherapeutic uterotonicsLow-certainty evidenceUterotonic agentsUmbilical veinMaternal mortalityPlasma expandersVein injectionUmbilical vein injection of oxytocinPrimary outcomeRisk ratioIncidence of blood transfusionMean differenceQuasi-randomisedChildbirth's Trials RegisterComplications of pregnancy
2020
Cochrane Review Summaries-October 2020.
O'Mathuna D, Berghella V, Bellussi F, Kumar N, Haas D. Cochrane Review Summaries-October 2020. Obstetrics And Gynecology 2020, 136: 844-846. PMID: 32925632, DOI: 10.1097/aog.0000000000004101.Peer-Reviewed Original ResearchConceptsReaders of Obstetrics & GynecologyPelvic floor muscle trainingObstetrics & GynecologyRecurrent pregnancy lossImprove pregnancy outcomesAntiphospholipid antibodiesGynecologic surgeryPregnancy outcomesPregnancy lossMuscle trainingCochrane systematic reviewsPerinatal periodPrevent incontinenceAdhesion barrierSystematic reviewPotential interventionsAntiphospholipidGynecologyIncontinenceSurgeryCochraneAntibodiesMonthsPriority setting for the Cochrane Pregnancy and Childbirth Group review updates: a Delphi process
Kumar N, Grant S, Haas D. Priority setting for the Cochrane Pregnancy and Childbirth Group review updates: a Delphi process. American Journal Of Obstetrics & Gynecology MFM 2020, 2: 100205. PMID: 33313498, PMCID: PMC7725470, DOI: 10.1016/j.ajogmf.2020.100205.Peer-Reviewed Original Research